• API CAS 956104-40-8 Apalutamide
  • API CAS 956104-40-8 Apalutamide
  • API CAS 956104-40-8 Apalutamide
  • API CAS 956104-40-8 Apalutamide
  • API CAS 956104-40-8 Apalutamide
  • API CAS 956104-40-8 Apalutamide

API CAS 956104-40-8 Apalutamide

Powder: Yes
Customized: Non-Customized
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Solid
Purity: >99%
Samples:
US$ 1/gram 1 gram(Min.Order)
| Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Trading Company

Basic Info.

Model NO.
TY-02ALI
CAS No.
956104-40-8
Appearance
White Powder
Einecs
616-396-9
Assay
99%
Shelf
2 Years
Transport Package
25kg/Drum 1kg, 10kg, 100kg, 200kg
Specification
25kg/drum
Trademark
tongyon
Origin
China
Production Capacity
5000kg/Month

Product Description

API CAS 956104-40-8 Apalutamide
API CAS 956104-40-8 Apalutamide

API CAS 956104-40-8 Apalutamide
 
Product name Apalutamide 
CAS 956104-40-8
Appearance white powder
Assay 99%
Storage Cool and Protect from light


API CAS 956104-40-8 Apalutamide

Product Name:Apalutamide 
CAS:956104-40-8
MF:C21H15F4N5O2S
MW:477.4347128
EINECS:807-449-9
Mol File:956104-40-8.mol  
Density 1.59±0.1 g/cm3(Predicted)
pka13.83±0.46(Predicted)


API CAS 956104-40-8 Apalutamide
Description
ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM in a cell-free assay, useful for prostate cancer treatment. Phase 3.
In vitroARN-509 (< 10 μM) inhibits androgen-mediated induction or repression of mRNA expression levels for 13 endogenous genes including PSA and TMPRSS2 in the LNCaP/AR prostate cancer cell line. ARN-509 (< 10 μM) inhibits the proliferative effect of R1881 (30 pM) in the LNCaP/AR prostate cancer cell line. ARN-509 (10 μM) impairs AR nuclear localization and thus reduces the concentration of AR available to bind androgen response elements (ARE) in LNCaP cells expressing AR-EYFP. ARN-509 (10 μM) is able to effectively compete with R1881 (1 nM) and prevent AR from binding to promoter regions. ARN-509 inhibits R1881-induced VP16-AR-mediated transcription with IC50 of 0.2 μM in Hep-G2 cells expressing a VP16-AR fusion protein and an ARE-driven luciferase reporter.


GuangZhou TongYi biochemistry technology Co., Ltd is a company specializing in active pharmaceutical ingredient
(API), biology, plant extracts, chemical raw materials, fine chemicals, pharmaceutical intermediates, cosmetics raw
material. Our company has always adhered to the company philosophy of integrity, professionalism, quality first, and
customer service. With the efforts of all the company's employees, it has established long-term
and stable cooperative relations with many domestic and foreign customers, and won the unanimous trust of domestic
and foreign customers. With good comments, our company have made great progress.


Our company takes pioneering and innovative, high-quality and efficient as the code of conduct, and strives to provide
customers with efficient services,
high-quality products, and reasonable prices. We have established a customer demand-oriented, flexible, diverse and customizable service according to the different needs of different customers. Mode, and ultimately achieve the goal of
win-win.


Our company focuses on the future and the world, and will continue to devote itself to technological progress and the
development of new products in the future, hoping to work hand in hand with new and old friends at home and abroad
to create a better future.


API CAS 956104-40-8 ApalutamideAPI CAS 956104-40-8 ApalutamideAPI CAS 956104-40-8 ApalutamideAPI CAS 956104-40-8 ApalutamideAPI CAS 956104-40-8 Apalutamide

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Trading Company
Number of Employees
2
Year of Establishment
2017-08-08